Personalized Hypoglycemia Outpatient Treatment - a Feasibility Study
NCT07094529 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2025-07-30
Summary
This study will offer two study interventions designed to bring on a mild low blood sugar (capillary blood glucose result 3.0 to 3.8 mmol/L), in order to study the effectiveness of each study participant's personal choice of treatment and first recheck time.
The two study interventions that the participant can choose to complete (one or both interventions).
Based on each participant's own experience with hypoglycemia treatment or their preferences, the participant can choose one of 4 simple carbohydrate treatment quantities, and choose one of 4 capillary blood glucose recheck times.
Conditions
- Type 2 Diabetes (T2DM)
- Hypoglycemia (Diabetic)
Interventions
- BEHAVIORAL
-
Recumbent Exercise Bike to induce mild hypoglycemia
The participant rides the recumbent exercise bike at their preferred speed and records the distance travelled until there is onset of mild hypoglycemia, determined by capillary blood glucose test result 3.0 to 3.8 mmmol/L. Based on each participant's own experience with hypoglycemia treatment or their preferences, the participant can choose one of 4 simple carbohydrate treatment quantities: 8 grams, 16 grams, 20 grams, 32 grams The participant can choose one of 4 capillary blood glucose recheck times: 15 minutes, 20 minutes, 25 minutes, 30 minutes.
- BEHAVIORAL
-
Delaying food to induce mild hypoglycemia,
At the study visit, in front of the study nurse, the participant takes their usual clinical care dose of sulfonylurea or basal insulin. If the participant's usual clinical care includes insulin with a rapid-acting component, then its dose is reduced based on the study protocol. No food intake (water is allowed) until there is onset of mild hypoglycemia, determined by a capillary blood glucose test result 3.0 to 3.8 mmol/L. Based on each participant's own experience with hypoglycemia treatment or their preferences, the participant can choose one of 4 simple carbohydrate treatment quantities: 8 grams, 16 grams, 20 grams, 32 grams The participant can choose one of 4 capillary blood glucose recheck times: 15 minutes, 20 minutes, 25 minutes, 30 minutes.
Sponsors & Collaborators
-
Ottawa Hospital Research Institute
lead OTHER
Principal Investigators
-
Cathy Sun, MD MSc · Ottawa Hospital Research Institute
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-21
- Primary Completion
- 2026-12-31
- Completion
- 2027-06-30
Countries
- Canada
Study Locations
More Related Trials
-
Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes
NCT04764968 ·Status: COMPLETED ·Phase: PHASE2
-
Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes
NCT02855307 ·Status: COMPLETED ·Phase: PHASE2
-
Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms
NCT02438189 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes
NCT03659799 ·Status: COMPLETED ·Phase: PHASE4
-
Low cArbohydraTe dIeT and aUtomated Insulin Delivery System for Type 1 DiabetEs
NCT05449678 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of The Postprandial Impact of Automated Priming Bolus for Full Closed Loop Insulin Delivery
NCT05528770 ·Status: COMPLETED ·Phase: NA
-
Outpatient Pump Shutoff Pilot Feasibility and Efficacy Study
NCT01591681 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility Study Assessing The Ability Of An Insulin Pump-Controlling Algorithm To Minimize Hypoglycemia And Hyperglycemia In Patients With Type 1 Diabetes In A Clinical Research Setting
NCT01401751 ·Status: COMPLETED ·Phase: NA
-
Study Assessing an Insulin Pump-controlling Algorithm to Minimize Hypo and Hyper in Type 1 During CRC Setting
NCT01638299 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia
NCT01919385 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility of Using the CGM During TOC From in Persons With T2D Using Insulin
NCT04533945 ·Status: COMPLETED ·Phase: NA
-
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
NCT00441129 ·Status: COMPLETED ·Phase: NA
-
Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
NCT00590226 ·Status: COMPLETED ·Phase: PHASE4
-
Suspending Basal Insulin Levels for Exercise in Adults With Type 1 Diabetes
NCT03034798 ·Status: COMPLETED
-
Insulin Management for Exercise in Patients With Type 1 Diabetes
NCT03130101 ·Status: COMPLETED ·Phase: NA
-
Pilot Study 3 of Outpatient Control-to-Range: Safety and Efficacy With Day-and-Night In-Home Use
NCT02137512 ·Status: COMPLETED ·Phase: NA
-
Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop
NCT02135068 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Monitoring Study
NCT02969863 ·Status: COMPLETED ·Phase: NA
-
Optimizing Metabolic Control in Type 1 Diabetes - The Automatic Bolus Calculator Flash Study
NCT03682237 ·Status: COMPLETED ·Phase: NA
-
Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes
NCT01697657 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes
NCT00922649 ·Status: COMPLETED ·Phase: NA
-
The SMART B Exercise Study :''The SMART Study''
NCT05133765 ·Status: COMPLETED ·Phase: NA
-
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
NCT05762107 ·Status: RECRUITING ·Phase: PHASE2
-
Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia
NCT02411578 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins
NCT00313742 ·Status: COMPLETED ·Phase: PHASE4